The mean change in body weight from baseline to the last treatment visit was 2.2 kg greater in the LANTUS group than in the standard care group
Uneven skin tone, dullness & impurities? Dermatouch Kojic Acid Soap (1%) cleanses, brightens & protects for radiant, healthy skin
Occasional small treats can be part of a balanced approach
Today, Novo Nordisk estimates that just under 20 million people are treated with GLP-1 drugs.4 Given a well-stocked pipeline, a substantial global addressable population (the obese population alone is projected to exceed 1.2 billion by 20305), and in light of the very beneficial clinical profile of these drugs, it is plausible that over 100 million patients worldwide will be treated with GLP-1s in the near future
In Europe, Germany is projected to lead the regional market by 2030, and Sweden is the fastest-growing market, with a projected revenue of $855.6 million USD by 2030